Redmile Group, LLC Abbott Laboratories Transaction History

Redmile Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $342,688 - $378,483	-3,129 Reduced 1.18%	262,371 $29.8 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $23.9 Million - $29.3 Million	265,500 New	265,500 $29.2 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $27.3 Million - $33 Million	-449,300 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $37.2 Million - $41.1 Million	-646,800 Reduced 59.01%	449,300 $27.4 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $11.2 Million - $12.7 Million	199,200 Added 22.21%	1,096,100 $0
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $48.1 Million - $51.5 Million	896,900	896,900 $51.2 Million

3,131

1.33B

8.63M

7.17M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.